Results-driven scientist with over 20 years of preclinical research experience in the biopharmaceutical industry. I have a proven track record in designing, implementing and analyzing preclinical studies in support of early discovery to late stage clinical drug candidates. Extensive experience utilizing preclinical cancer models ranging from bioluminescent xenograft models for tumor metastasis to bone to subcutaneous syngeneic models with immune-mediated tumor rejection. I have been successful working as an individual as well as a key team member for projects at all phases of preclinical development including drug target identification/validation, drug development. Proven record of scientific presentations and publications and a effective manager of Senior Associate Scientist